165 related articles for article (PubMed ID: 27340318)
21. Diagnostic and prognostic values of preoperative serum levels of YKL-40, HE-4 and DKK-3 in endometrial cancer.
Kemik P; Saatli B; Yıldırım N; Kemik VD; Deveci B; Terek MC; Koçtürk S; Koyuncuoğlu M; Saygılı U
Gynecol Oncol; 2016 Jan; 140(1):64-9. PubMed ID: 26607777
[TBL] [Abstract][Full Text] [Related]
22. Tumor-associated trypsin inhibitor in patients with endometrial cancer.
Kozakiewicz B; Chądzyńska M; Dmoch-Gajzlerska E; Stefaniak M
Tumori; 2016 Oct; 102(5):527-532. PubMed ID: 26350184
[TBL] [Abstract][Full Text] [Related]
23. High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer.
Bellone S; Watts K; Cane' S; Palmieri M; Cannon MJ; Burnett A; Roman JJ; Pecorelli S; Santin AD
Gynecol Oncol; 2005 Jul; 98(1):92-8. PubMed ID: 15904949
[TBL] [Abstract][Full Text] [Related]
24. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor.
Kaminska J; Kowalska M; Kotowicz B; Fuksiewicz M; Glogowski M; Wojcik E; Chechlinska M; Steffen J
Oncology; 2006; 70(2):115-25. PubMed ID: 16645324
[TBL] [Abstract][Full Text] [Related]
25. Hematopoietic growth factors in colorectal cancer patients.
Mroczko B; Szmitkowski M; Okulczyk B
Clin Chem Lab Med; 2003 May; 41(5):646-51. PubMed ID: 12812262
[TBL] [Abstract][Full Text] [Related]
26. Clinical value of tumour specific growth factor (TSGF) and carbohydrate antigen-125 (CA-125) in carcinoma of the endometrium.
Yu B; Xu PZ; Wang QW; Zhou H; Zhou HX
J Int Med Res; 2009; 37(3):878-83. PubMed ID: 19589273
[TBL] [Abstract][Full Text] [Related]
27. Possible role of interleukin 21 and interleukin 33 in patients with genital warts.
Abu El-Hamd M; Assaf HAR; Sedky A; Mohammad SH
Dermatol Ther; 2019 Sep; 32(5):e13063. PubMed ID: 31414711
[TBL] [Abstract][Full Text] [Related]
28. The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma.
Li Z; Xu H; Yu J; Liu C; Zheng C; Zeng R; Xu L; Li E; Peng Y; Xu Y
Cancer Control; 2021; 28():10732748211004883. PubMed ID: 33926265
[TBL] [Abstract][Full Text] [Related]
29. The Association of Serum IL-33 and sST2 with Breast Cancer.
Yang ZP; Ling DY; Xie YH; Wu WX; Li JR; Jiang J; Zheng JL; Fan YH; Zhang Y
Dis Markers; 2015; 2015():516895. PubMed ID: 26456994
[TBL] [Abstract][Full Text] [Related]
30. SERUM CYTOKINE OF IL-2, IL-10 AND IL-12 LEVELS IN PATIENTS WITH STOMACH ADENOCARCINOMA.
Shokrzadeh M; Mohammadpour A; Hoseini V; Abediankenari S; Ghassemi-Barghi N; Tabari YS
Arq Gastroenterol; 2018; 55(4):385-389. PubMed ID: 30785523
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of RCAS1 as a biomarker of uterine cancer.
Sonoda K; Miyamoto S; Hirakawa T; Yagi H; Yotsumoto F; Nakashima M; Watanabe T; Nakano H
Gynecol Oncol; 2006 Dec; 103(3):924-31. PubMed ID: 16842844
[TBL] [Abstract][Full Text] [Related]
32. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
[TBL] [Abstract][Full Text] [Related]
33. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
Knychalski B; Lukieńczuk T
Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
[TBL] [Abstract][Full Text] [Related]
34. HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET).
Antonsen SL; Høgdall E; Christensen IJ; Lydolph M; Tabor A; Loft Jakobsen A; Fagö-Olsen CL; Andersen ES; Jochumsen K; Høgdall C
Acta Obstet Gynecol Scand; 2013 Nov; 92(11):1313-22. PubMed ID: 24032654
[TBL] [Abstract][Full Text] [Related]
35. Association between visceral fat, IL-8 and endometrial cancer.
Ciortea R; Mihu D; Mihu CM
Anticancer Res; 2014 Jan; 34(1):379-83. PubMed ID: 24403491
[TBL] [Abstract][Full Text] [Related]
36. Development of serum parameters panels for the early detection of pancreatic cancer.
Zhang P; Zou M; Wen X; Gu F; Li J; Liu G; Dong J; Deng X; Gao J; Li X; Jia X; Dong Z; Chen L; Wang Y; Tian Y
Int J Cancer; 2014 Jun; 134(11):2646-55. PubMed ID: 24615168
[TBL] [Abstract][Full Text] [Related]
37. Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance.
Brennan DJ; Hackethal A; Mann KP; Mutz-Dehbalaie I; Fiegl H; Marth C; Obermair A
BMC Cancer; 2015 Feb; 15():33. PubMed ID: 25655024
[TBL] [Abstract][Full Text] [Related]
38. Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome.
Zanotti L; Bignotti E; Calza S; Bandiera E; Ruggeri G; Galli C; Tognon G; Ragnoli M; Romani C; Tassi RA; Caimi L; Odicino FE; Sartori E; Pecorelli S; Ravaggi A
Clin Chem Lab Med; 2012 Dec; 50(12):2189-98. PubMed ID: 23096757
[TBL] [Abstract][Full Text] [Related]
39. Serum interleukin measurement may help identify thyroid cancer patients with active disease.
Martins MB; Marcello MA; Batista FA; Peres KC; Meneghetti M; Ward MAL; Etchebehere ECSC; da Assumpção LVM; Ward LS
Clin Biochem; 2018 Feb; 52():1-7. PubMed ID: 28987791
[TBL] [Abstract][Full Text] [Related]
40. A New Diagnostic and Prognostic Marker in Endometrial Cancer: Neopterin.
Isci Bostanci E; Ugras Dikmen A; Girgin G; Gungor T; Baydar T; Nuri Danisman A
Int J Gynecol Cancer; 2017 May; 27(4):754-758. PubMed ID: 28383326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]